Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.

Alexandra Bach-Weidmuller, Head of Program and Project Management at NIBR, describes her path to leadership as lateral instead of upward.

In Guatemala, social worker Eduardo Canuz fights logistical and cultural challenges while preventing women and infants from inhaling smoke.

While the country has made great strides in controlling AIDS and other infectious diseases, Kenyans are living longer and chronic diseases such as diabetes, heart disease and cancer are on the rise.

Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

Novartis immunologist describes the excitement of discovering a promising new immuno-oncology (IO) target in the treatment of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).

New Global Head of Cardiovascular and Metabolic Diseases Research looks to apply new tools to address tough challenges.

A complex protein module keeps the liver’s biochemical factory running smoothly and at capacity.

Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.

Marc Pelletier traveled from Cambridge, MA to Shanghai, China, to launch new lines of research for the treatment of cancers that are common in China.